FL CARES: Cancer Drug Property Dataset

Brand Name:
Code(s): EMD 1214063
Approved:
Kinase Class: RY
Inhibitor Type: I ½B
Literature (PubMed): <a href="https://pubchem.ncbi.nlm.nih.gov/compound/#section=Literature" target="_blank"> 0
Target(s): MET proto-oncogene, receptor tyrosine kinase
Disease(s): non-small-cell lung carcinoma

Tepotinib US FDA Label

Compound: 3-[1-[[3-[5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl]phenyl]methyl]-6-oxopyridazin-3-yl]benzonitrile
Description: NA

International Nonproprietary Name: Tepotinib [INN] (Source: PubChem)

KEGG Drug ID: D11717 (Source: PubChem)

USFDA Precision ID: UNII-1IJV77EI07 (Source: PubChem)

US Adopted Name: Tepotinib [USAN] (Source: PubChem)

Sources: PubChem (4)